PERSPECTA

News from every angle

← Back to headlines

Scholar Rock Outlines 2026 Apitegromab BLA Resubmission and Commercial Launch

Scholar Rock has provided an update on its plans for apitegromab, outlining a BLA resubmission and commercial launch in 2026 following progress with the FDA.

3 Mar, 21:42 — 3 Mar, 21:42
PostShare
ℹOnly 1 source covers this story

Read at source (1 outlet)

seeking-alpha23h ago

Scholar Rock outlines 2026 apitegromab BLA resubmission and commercial launch following FDA progress

Read full article →

Related Stories

UK, EU, and Türkiye Energy Equation Post-Brexit

6m ago

Women's Representation on Dutch Company Boards Continues to Rise

7m ago

Judge Gives Green Light to Billion-Dollar Settlement in Roundup Lawsuits

13m ago

Graffiti-Covered Los Angeles Skyscrapers Find a Buyer

17m ago